期刊文献+

EXPRESSION OF mRNA FOR MEMBRANE-TYPE 1, 2, AND 3 MATRIX METALLOPROTEINASES IN HUMAN LARYNGEAL CANCER 被引量:5

EXPRESSION OF mRNA FOR MEMBRANE-TYPE 1, 2, AND 3 MATRIX METALLOPROTEINASES IN HUMAN LARYNGEAL CANCER
下载PDF
导出
摘要 To investigate correlation of expressions of membrane-type 1, 2, and 3 matrix metalloproteinases (MT1, MT2, and MT3-MMP) to the invasion and metastases in laryngeal cancer. Methods Reverse transcription-polymerase chain reaction (RT-PCR) was used to examine the mRNA level of MT1, MT2, and MT3-MMP in 24 patients with laryngeal cancer. The relationships of these three MT-MMP expressions to clinico-pathology were analyzed by statistics. Results The expressions of MT1, MT2, and MT3-MMP were significantly higher in laryngeal cancer tissues than those in para-tumorous tissues (P < 0.01) and had a close relationship with invasive depth (P < 0.05). But no significantly different expressions of these three MT-MMPs were found in different primary location and different histological grade of laryngeal cancer (P > 0.05). The expression of MT1-MMP was obviously higher in patients with metastatic lymph nodes than that in patients without metastatic lymph nodes (P < 0.05). Conclusion MT1, MT2, and MT3-MMP play an important role in the progression of laryngeal cancer, and MT1-MMP may serve as a reliable marker in estimating invasive and metastatic potency of laryngeal cancer. Suppressing expressions of MT1, MT2, and MT3-MMP early may inhibit the invasion and metastases of laryngeal cancer.
机构地区 DepartmentofEars
出处 《Chinese Medical Sciences Journal》 CAS CSCD 2004年第3期170-173,共4页 中国医学科学杂志(英文版)
关键词 laryngeal cancer membrane type matrix metalloproteinases polymerase chain reaction 基因表达 mRNA 隔膜 金属蛋白质 基质 1型 2型 3型 人类 喉癌 肿瘤
  • 相关文献

参考文献12

  • 1[1]Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their role in tumor invasion and metastasis. Eur J Cancer 2000;36:1621-30.
  • 2[2]Vihinen P, Kahari VM. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 2002;99:157-66.
  • 3[3]Yana I, Seiki M. MT-MMPs play pivotal roles in cancer dissemination. Clin Exp Metastasis 2002;19:209-15.
  • 4[4]Lang R, Braun M, Sounni NE, et al. Crystal structure of the catalytic domain of MMP-16/MT3-MMP: characterization of MT-MMP specific features. J Mol Biol 2004;336:213-25.
  • 5[5]Jiang A, Pei D. Distinct roles of catalytic and pexin-like domains in membrane-type matrix metalloproteinase (MMP)-mediated proMMP-2 activation and collagenolysis. J Biol Chem 2003;278:38765-71.
  • 6[6]Ueno H, Nakamura H, Inoue M, et al. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 1997;57:2055-60.
  • 7[7]Nakamura H, Ueno H,Yamashita K, et al. Enhanced production and activation of progelatinase A mediated by membrane-type 1matrix metalloproteinase in human papillary thyroid carcinomas.Cancer Res 1999;59:467-73.
  • 8[8]Kang T, Yi J, Yang WR, et al. Functional characterization of MT3-MMP in transfected MDCK cells: progelatinase A activation and tubulogenesis in 3-D collagen lattice. FASEB J 2000;14:2559-68.
  • 9[9]Kitagawa Y, Kunimi K, Uchibayashi T, etal. Expression of messenger RNAs for membrane-type 1, 2, and 3 matrix metalloproteinases in human renal cell carcinomas. J Urol 1999;162:905-9.
  • 10[10]Nuttall RK, Pennington CJ, Taplin J, et al. Elevated membranetype matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells. Mol Cancer Res2003;1:333-45.

同被引文献7

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部